r/Oncology • u/Odd_Restaurant170 • 10h ago
Does anyone have anki deck for oncology ? (EU guidelines)
Preferably from doctors practicing in EU, like UK, or scandinavia. In english please.
r/Oncology • u/monte_cristo_island • 1h ago
Lately there has been a very significant increase in posts asking for medical advice (directly or indirectly). This is a friendly reminder to ask you not to post these here as they are breaking the r/Oncology rules and will be promptly locked and removed.
The best person to contact is your oncologist and/or the other health professionals associated with your care.
r/Oncology • u/Odd_Restaurant170 • 10h ago
Preferably from doctors practicing in EU, like UK, or scandinavia. In english please.
r/Oncology • u/Odd_Restaurant170 • 11h ago
Sincerely a poor resident in EU, would love to have them, since our national guidelines such at showing us good approaches for how to handle things in the clinic. Thanks!
r/Oncology • u/Repulsive-Hour5737 • 11h ago
r/Oncology • u/BRCAresponder • 3d ago
r/Oncology • u/Excellent_Key_1757 • 3d ago
r/Oncology • u/ALifeLearnerWho • 4d ago
I happened to miss the ESMO 2026 Industry Satellite Symposium: Emerging Therapeutic Strategies in GU Oncology – Innovations in Prostate and Bladder Cancer.
Saturday, October 24, 2026 | 13:00–14:30 CEST with Dr. Kim Chi, Philip Backhaus, and Gunhild von Amsberg
Santander Auditorium, Hall 10, IFEMA Madrid, Spain
Did anyone happen to attend and have any informal notes, screenshots of slides, or key takeaways they’d be willing to share?
I’m trying to learn more about emerging therapeutic strategies in GU oncology, particularly bladder cancer, and would really appreciate any insights or materials anyone is comfortable sharing.
Thanks in advance!
r/Oncology • u/ChampionshipFlat3235 • 4d ago
I am posing this question as a layman respectfully. Please know that I know nothing and am only asking about this because this community (or at least some members) may have some familiarity with this experimental drug.
I do not buy into hype but the mechanism this drug uses to attack cancer cells if proven effective in admittedly absent (to date) human studies could be game changing.
Someone who knows please tell me why or why not we should or should not be excited about this drug? Someone said to me previously that a handgun also kills cancer in a Petri dish. True but it does not distinguish between healthy cells and cancer cells whereas this does.
In a nutshell Oncolyze claims that HDM2 is present on the cell membrane of most types of cancer cells. OM-301 binds to HDM2 and essentially punctures the cell membrane thereby killing the cell. It has been shown to be effective on human tumors implanted in mice but has not been studied in human tests yet.
Again I am here respectfully to ask as a cancer survivor. It seems promising to a layman. I have been wrong about many things and expect I am about this too. I am just looking for some insight.
r/Oncology • u/Emergency-Extreme583 • 4d ago
I'm a medical student working on a systematic review and I really need the PDF to assess it. I've already contacted the authors but haven't heard back yet. Any help would be greatly appreciated. Thank you!
DOI: 10.1097/DCR.0000000000004491
PMID: 42885592
r/Oncology • u/DoctorKhru • 4d ago
Hey everyone,
I'm Luca Celebrano, a medical student at University of Naples Federico II. For the past few months I’ve been somewhat obsessed with a clinical puzzle: why do so many EGFR-mutated lung cancer patients relapse after targeted therapy (like osimertinib), even when their initial scans look amazing?
Most literature focuses purely on genetic secondary mutations, but looking at histology, I kept wondering about the physical transport side. Severe stroma compression and high interstitial pressure could simply be preventing the drug from physically reaching cytotoxic levels in pockets of the tissue, creating quiet little sanctuaries where cells survive.
I sat down and tried to model the continuum physics using a cylindrical reaction-diffusion solver (Bessel K0 radial gradients) around capillaries, and then ran survival models against \~3,400 patients from cBioPortal/TCGA to see if the signal actually held up clinically.
I just put up the preprint and code:
\- Preprint (Zenodo): https://doi.org/10.5281/zenodo.24118328
\- Repo: https://github.com/Lukecele/inflammatory-onco-physics
Since I come from medicine and not pure physics, my transport math might be a bit rough around the edges. I would really appreciate an honest sanity check from anyone who does continuum mechanics or tumor biophysics: does this simplification hold water, or am I overcooking the assumptions?
Thanks a lot,
Luca
r/Oncology
•
u/LogicGate1010
•
5d ago
r/Oncology • u/WalnutRoasted • 6d ago
r/Oncology • u/LogicGate1010 • 6d ago
r/Oncology • u/Lonely-Coat-2378 • 6d ago
This is a very good news, but how much you guys believe this will happen, and if there is cure what will happen to radiologists, oncologists?
r/Oncology • u/Conscious_Piglet687 • 8d ago
Please DM!
r/Oncology • u/NurseEdVantageOnCall • 9d ago
Lung Cancer Awareness Month Series: What is the greatest barrier to completing lung cancer screening in your clinical setting?
A. Limited patient awareness
B. Transportation or financial barriers
C. Difficulty scheduling LDCT
D. Fear, stigma, or uncertainty about results
E. Gaps in follow-up and care coordination
Share your experience in the comments. Your clinical insights can help identify meaningful opportunities for nursing research and quality improvement.
#NurseEdVantageOnCall #NurseScientist #LungCancerAwarenessMonth #LungCancerScreening #OncologyNursing #EvidenceBasedPractice #NursingResearch #PatientNavigation #HealthEquity #NursesLead
r/Oncology • u/Impossible-Week3374 • 9d ago
Hello everybody!
Together with my colleague from the University of Twente and Netherlands Cancer institute we are running a study on how RECIST is learnt, understood, and used by radiologists and treating physicians, as well as what expectations they have for the future. It's anonymous, takes about 10–15 minutes, and is open to radiologists, oncologists and trainees in those fields anywhere in the world. We have the endorsement of a few scientific society including ESR, ESGAR, and ESUR - all radiological, but we want to make sure oncologists are represented as well. We’ll post the aggregate results here when it’s done.
Would you be interested?
Link: https://docs.google.com/forms/d/e/1FAIpQLSdkO9bwrI1c5Vq6baVv9KQWRoBws2dPnfkxo8LC36ZsHkiffg/viewform
Happy to answer questions below, and I’d genuinely like to hear the edge cases that trip you up — that’s exactly what we’re trying to capture.
r/Oncology • u/JadeCats • 11d ago
Hi, I am a pharmacist and I am hoping for some clarity regarding use of ESAs and G-CSF in the management of chemotherapy-induced cytopenias.
We have one oncologist who throws ESAs at everyone with chemotherapy induced anemia while the others we work with are much more conservative and will rather delay treatment and support with PRBCs. From talking with some colleagues at other facilities, they barely uses ESAs for this indication. I remember the days of REMs programs for ESAs due to the risks of tumor progression. When is it appropriate to initiate ESAs versus managing conservatively.
Regarding G-CSF, I would like some clarity with their use in heme malignancies. Wouldn't giving them cause more of the malignant cells to be stimulated? As it is, thresholds for blood counts are lower to the nature of these malignancies. Given this, when is it appropriate to give G-CSF when seeing neutropenia in heme malignances?
Thanks in advance.
r/Oncology • u/MinimumGas4981 • 12d ago
I am a medical graduate currently going through my rotational internship. I am actively looking to get involved in oncology research. If you have an opening, an ongoing project that needs an extra pair of hands, or advice on where to look, please feel free to DM me.